Laboratoires Bouchara Recordati S.A.S.
Laboratoires Bouchara Recordati S.A.S., a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 1821, the company has a rich history marked by significant milestones, including its integration into the Recordati Group, which has bolstered its market presence. Specialising in the development and manufacturing of innovative pharmaceutical products, Laboratoires Bouchara Recordati focuses on niche therapeutic areas such as rare diseases and specialty pharmaceuticals. Their unique offerings, characterised by high-quality standards and advanced formulations, set them apart in a competitive landscape. With a strong commitment to research and development, the company has achieved notable recognition in the industry, solidifying its position as a trusted provider of effective healthcare solutions.
DitchCarbon Score
How does Laboratoires Bouchara Recordati S.A.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laboratoires Bouchara Recordati S.A.S.'s score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laboratoires Bouchara Recordati S.A.S.'s reported carbon emissions
Laboratoires Bouchara Recordati S.A.S., headquartered in France, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to establish clear targets for reducing greenhouse gas emissions across all scopes. As the industry evolves, it is anticipated that Laboratoires Bouchara Recordati S.A.S. will develop and disclose its climate strategies and emissions data in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratoires Bouchara Recordati S.A.S. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
